Kinome-Wide Functional Genomics Screen Reveals a Novel Mechanism of TNFα-Induced Nuclear Accumulation of the HIF-1α Transcription Factor in Cancer Cells
Hypoxia-inducible factor-1 (HIF-1) and its most important subunit, HIF-1α, plays a central role in tumor progression by regulating genes involved in cancer cell survival, proliferation and metastasis. HIF-1α activity is associated with nuclear accumulation of the transcription factor and regulated by several mechanisms including modulation of protein stability and degradation. Among recent advances are the discoveries that inflammation-induced cytokines and growth factors affect protein accumulation of HIF-1α under normoxia conditions. TNFα, a major pro-inflammatory cytokine that promotes tumorigenesis is known as a stimulator of HIF-1α activity. To improve our understanding of TNFα-mediated regulation of HIF-1α nuclear accumulation we screened a kinase-specific siRNA library using a cell imaging–based HIF-1α-eGFP chimera reporter assay. Interestingly, this systematic analysis determined that depletion of kinases involved in conventional TNFα signaling (IKK/NFκB and JNK pathways) has no detrimental effect on HIF-1α accumulation. On the other hand, depletion of PRKAR2B, ADCK2, TRPM7, and TRIB2 significantly decreases the effect of TNFα on HIF-1α stability in osteosarcoma and prostate cancer cell lines. These newly discovered regulators conveyed their activity through a non-conventional RELB-depended NFκB signaling pathway and regulation of superoxide activity. Taken together our data allow us to conclude that TNFα uses a distinct and complex signaling mechanism to induce accumulation of HIF-1α in cancer cells. In summary, our results illuminate a novel mechanism through which cancer initiation and progression may be promoted by inflammatory cytokines, highlighting new potential avenues for fighting this disease.
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860–867.
[3]
Wang X, Lin Y (2008) Tumor necrosis factor and cancer buddies or foes? Acta Pharmacol Sin 29: 1275–1288.
[4]
Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29(5): 625–634.
[5]
Frede S, Berchner-Pfannschmidt U, Fandrey J (2007) Regulation of hypoxia-inducible factors during inflammation. Meth Enzymol 435: 405–419.
[6]
Haddad JJ, Land SC (2001) A non-hypoxic ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett 505: 269–274.
[7]
Albina JE, Mastrofrancesco B, Vessella JA, Louis CA, Henry WL Jr, et al. (2001) HIF-1 expression in healing wounds: HIF-1α induction in primary inflammatory cells by TNF-α. Am J Physiol Cell Physiol 281: C1971–1977.
[8]
Hellwig-Bürgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W (1999) Interleukin-1beta and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561–1567.
[9]
MacEwan DJ (2002) TNF ligands and receptors -a matter of life and death. Br J Pharmacol 135: 855–875.
[10]
Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, et al. (2006) Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA 12: 1197–1205.
[11]
Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001) Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279–284.
[12]
Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, et al. (2005) RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion survival and tumorigenicity in vivo. J Biol Chem 280(43): 36529–40.
[13]
Cash TP, Pan Y, Simon MC (2007) Reactive oxygen species and cellular oxygen sensing. Free Radic Biol Med 43: 1219–1225.
[14]
K?hl R, Zhou J, Brüne B (2006) Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1α stabilization. Free Radic Biol Med 40: 1430–1442.
[15]
Han D, Ybanez MD, Ahmadi S, Yeh K, Kaplowitz N (2009) Redox regulation of tumor necrosis factor signaling. Antioxid Redox Signal 11: 2245–2263.
[16]
Imlay JA (2008) Cellular defenses against superoxide and hydrogen peroxide. Annu Rev Biochem 77: 755–776.
[17]
Mercurio F, Manning AM (1999) NF-kappaB as a primary regulator of the stress response. Oncogene 18: 6163–6171.
[18]
Chen RQ, Yang QK, Chen YL, Oliveira VA, Dalton WS, et al. (2009) Kinome siRNA screen identifies SMG-1 as a negative regulator of hypoxia-inducible factor-1α in hypoxia. J Biol Chem 284: 16752–16758.
[19]
Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, et al. (2009) Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Physiol Cell Physiol 297: C493–502.
[20]
Iorns E, Lord CJ, Grigoriadis A, McDonald S, Fenwick K, et al. (2009) Integrated functional gene expression and genomic analysis for the identification of cancer targets. PLoS ONE 4e5120. Available: http://www.plosone.org/article/info%3Ado?i%2F101371%2Fjournal.pone.0005120. Accessed 2012 Jan 26.
[21]
Grandinetti KB, Stevens TA, Ha S, Salamone R, J Walker JR, et al. (2011) Overexpression of TRIB2 in human lung cancers contributes to tumorigenesis through downregulation of C/EBPα. Oncogene 30: 3328–35.
[22]
Keeshan K, Shestova O, Ussin L, Pear WS (2008) Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia. Blood Cells Mol Dis 40: 119–121.
[23]
Taskén K, Sk?lhegg BS, Taskén KA, Solberg R, Knutsen HK, et al. (1997) Structure function and regulation of human cAMP-dependent protein kinases. Adv Second Messenger Phosphoprotein Res 31: 191–204.
[24]
Yee NS, Zhou W, Liang IC (2011) Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer. Dis Model Mech 4: 240–254.
[25]
Jaspers I, Zhang W, Fraser A, Samet JM, Reed W (2001) Hydrogen peroxide has opposing effects on IKK activity and IkappaBα breakdown in airway epithelial cells. Am J Respir Cell Mol Biol 24: 769–777.
[26]
Sonenshein GE (1997) Rel/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol 8: 113–119.